PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Projects
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Pricing and Market Access
Events
Reports
Premium Insights
Excellence Awards
Magazine
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Accelerating Clinical Trials
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Projects
Latest
US companies drive 2023 drug launches positioned for blockbuster success by 2028
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter
Why is the healthcare industry hesitant to join the metaverse?
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
Betta to commercialise C4 Therapeutics’ CFT8919 in greater China
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
FDA accepts Bristol Myers Squibb’s repotrectinib NDA for review
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
University of Sydney will use AI to boost cancer drug research
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Who’s saying what? Microbiome mentions in company filings of pharmaceutical industry decreased by 30% in Q1 2023
Who’s saying what? Blockchain mentions in company filings of pharmaceutical industry increased by 17% in Q1 2023
Who’s saying what? Orphan Designated Drugs mentions in company filings of pharmaceutical industry decreased by 18% in Q1 2023
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Latest
Medicines adherence: Overcoming pharma’s biggest barrier to treatment success
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Events
Reports
Premium Insights
PT
May 9, 2022
3rd Annual Gene Therapy for Neurological Disorders Europe
By
IndiaProduction
IndiaProduction
Share this article
Recommended Reports
Reports
3rd World Congress on Controversies in Ophthalmology 2012 - Post-Conference Review and Analysis
GlobalData
Reports
PharmaPoint: Alzheimer’s Disease – Global Drug Forecast and Market Analysis to 2023
GlobalData
View all
IndiaProduction
